Entecavir surprise

被引：12

作者：

Hirsch, Martin S. ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[2] Partners AIDS Res Ctr, Cambridge, MA USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 356卷 / 25期

关键词：

D O I：

10.1056/NEJMe078045

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2641 / 2643

页数：3

共 11 条

[1] THE INFLUENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION ON THE DEVELOPMENT OF THE HEPATITIS-B VIRUS CARRIER STATE [J].

BODSWORTH, NJ ;

COOPER, DA ;

DONOVAN, B .

JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (05) :1138-1140

[2]

*DHHS PAN ANT GUID, 2006, ENT HEP B VIR HBV HI

[3]

*DHHS PAN ANT GUID, 2006, GUID US ANT AG HIV 1

[4] Identification of EMS-200475 as a potent and selective inhibitor of hepatitis B virus [J].

Innaimo, SF ;

Seifer, M ;

Bisacchi, GS ;

Strandring, DN ;

Zahler, R ;

Colonno, RJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1444-1448

[5] Antiretroviral therapy for hepatitis B virus - HIV - Coinfected patients: Promises and pitfalls [J].

Levy, Vivian ;

Grant, Robert M. .

CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :904-910

[6] Brief report - The HBV drug entecavir - Effects on HIV-1 replication and resistance [J].

McMahon, Moira A. ;

Jilek, Benjamin L. ;

Brennan, Timothy P. ;

Shen, Lin ;

Zhou, Yan ;

Wind-Rotolo, Megan ;

Xing, Sifei ;

Bhat, Shridhar ;

Hale, Braden ;

Hegarty, Robert ;

Chong, Curtis R. ;

Liu, Jun O. ;

Siliciano, Robert F. ;

Thio, Chloe L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (25) :2614-2621

[7] CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression [J].

Moore, Richard D. ;

Keruly, Jeanne C. .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (03) :441-446

[8] When should antiretroviral therapy for HIV be started? [J].

Phillips, Andrew N. ;

Gazzard, Brian G. ;

Clumeck, Nathan ;

Losso, Marcelo H. ;

Lundgren, Jens D. .

BRITISH MEDICAL JOURNAL, 2007, 334 (7584) :76-78

[9] Risk of selecting K65R in anti retroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir [J].

Sheldon, JA ;

Corral, A ;

Rodés, B ;

Mauss, S ;

Rockstroh, J ;

Berger, F ;

Schwarze-Zander, C ;

Soriano, V .

AIDS, 2005, 19 (17) :2036-2038

[10] HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) [J].

Thio, CL ;

Seaberg, EC ;

Skolasky, R ;

Phair, J ;

Visscher, B ;

Muñoz, A ;

Thomas, DL .

LANCET, 2002, 360 (9349) :1921-1926

← 1 2 →